Poor prospects for Ozempic maker print on Danish economy
The Success of Ozempic, Novo Nordisk’s Popular Diabetes and Weight Loss Drug, Boosted the Danish Economy for Years. Due to Increasing Competition in the United States, Both the Company’s Revenue and Denmark’s Economic Growth Are Being Hit hard. Previously, Novo Nordisk Grew Rapidly Thanks to the High Demand for Diabetes Drugs Ozempic and Wegovy. The […]









